Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo7wHUmK #bloodpressure #heartdisease @AnnalsofIM @UPennDBEI @PennKidney @PennMedNews 1/4
Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2019 – Nov 2024Where it's discussed
-
X / Twitter91 posts
-
News77 articles
-
Facebook12 posts
-
Blogs6 articles
-
Bluesky2 posts
-
YouTube2 videos
AI synopsis
What people are saying
The group's conversations demonstrate high engagement and agreement, with posts citing meta-analyses and calling for action, such as recommending home blood pressure monitoring, and emphasizing the risks of untreated white coat hypertension, which shows their recognition of the article’s impact on medical practice. Words like 'urgent,' 'doubled risk,' and references to specific studies contribute to the impression that these discussions are both meaningful and impactful in clinical settings.
Most discussions recognize the evidence linking untreated white coat hypertension to increased cardiovascular risks, showing support for the study's conclusions.
The topic of white coat hypertension and its risks sparks strong interest, with many posts emphasizing its importance and debating treatment implications.
Posts include references to recent meta-analyses and specific studies, indicating deep engagement through sharing data, referencing trials, and discussing management strategies.
The discussions highlight how this research influences clinical awareness and patient management, emphasizing the need for out-of-office monitoring and recognition of white coat effects as significant.
Abstract in brief
- Untreated white coat hypertension (WCH) is linked to a higher risk of cardiovascular events, all-cause mortality, and cardiovascular mortality compared to normal blood pressure, while treated white coat effect (WCE) does not show a significant increased risk.
- The study emphasizes the importance of out-of-office blood pressure monitoring for accurate diagnosis and management of hypertension, as the risks associated with untreated WCH remain notable.
- The research highlights a need for further studies, especially on specific cardiac outcomes and diverse participant groups, to better understand the long-term risks associated with white coat hypertension.
Top posts
Most liked on X and Bluesky正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern Med 2019; 170: 853-62) https://t.co/vbhiHSB0Av
@DrGRuralMD All the folks saying it’s just “white coat HTN….” My generation of trainees has been taught to not write it off https://t.co/72mpD0ILLA
Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/OZqP7IKhuU @AnnalsofIM Tx @drjosflynn for sharing
@PaulNWilliamz Yes, yes, and yes! We did a meta-analysis showing this
@amjhypertension also see an excellent SR from @jordy_bc and colleagues here https://t.co/w5VMUxyhVN in @AnnalsofIM https://t.co/RR8mpWdrTW
All mentions
Understanding Low Blood Pressure and Heart Health Risks
Cardiovascular diseases are the leading cause of death worldwide. This video addresses various questions about blood pressure and other heart-related conditions, providing insights drawn from scientific research and…
Cardiovascular Risks of Untreated White Coat Hypertension
This video discusses the findings from a systematic review and meta-analysis exploring cardiovascular events and mortality in individuals with untreated white coat hypertension. It emphasizes the importance of…
@spjuraschek Yes and no. I think yes for masked. But for treated white coat effect, lots of data suggest that the elevated office readings aren't associated with long-term risk https://t.co/Cvzh36a9aq Looking forward to the discussion!
Ojo con la hipertensión de bata blanca es urgente tener un tensiometro en casa para confirmar los valores y tratar. no se confíe pensando que es solo en el consultorio. mas muerte CV y eventos vs tensión normal . 2019 Jun 18;170(12):853-862.Ann Intern Med doi: 10.7326/M19-0223. https://t.co/zol2iS8hjj
@PaulNWilliamz Yes, yes, and yes! We did a meta-analysis showing this
3/ we could both over or undertreating our patients, because we all know office measured BP, as perfect as technique might be, there are pt depending fa tor biases (ha.. white coat HTN etc) https://pubmed.ncbi.nlm.nih.gov/31181575/
3/ we could both over or undertreating our patients, because we all know office measured BP, as perfect as technique might be, there are pt depending fa tor biases (ha.. white coat HTN etc) https://t.co/GtVhhPDQBu https://t.co/3RKjqapVzS
https://t.co/5Hztzx4zlk
@amjhypertension also see an excellent SR from @jordy_bc and colleagues here https://t.co/w5VMUxyhVN in @AnnalsofIM https://t.co/RR8mpWdrTW
@joshmcgoo So no one here has heard of the Sprint study? Or how about the dangers of untreated white coat hypertension? https://t.co/8g4N7Pasba
Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis: Annals of Internal Medicine: Vol 170, No 12 https://t.co/JSaf74irlC
RT @Doctoklahoma: @DrGRuralMD All the folks saying it’s just “white coat HTN….” My generation of trainees has been taught to not write it o…
@DrGRuralMD All the folks saying it’s just “white coat HTN….” My generation of trainees has been taught to not write it off https://t.co/72mpD0ILLA
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
TUESDAY NEWSDAY! https://t.co/qbrFZ0ZLy1 Do you suffer from "White Coat Hypertension?" You ARE twice as likely to die from heart disease or stroke than the person who always has a normal BP reading! READ MORE:
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
RT @EARL_Med_Tw: 正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern…
正常血圧患者に比して,無治療の白衣高血圧患者は心血管イベントリスクが1.36倍,全死亡リスクが1.33倍,心血管死リスクが2.09倍増加.治療を受けている白衣高血圧患者ではリスク増加はみられず.27報64273例メタ解析(Ann Intern Med 2019; 170: 853-62) https://t.co/vbhiHSB0Av
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
Afraid of the White Coat?... Enriching Primary Eyecare Through Clinical Medicine Cases, Insight, Perspective in my FB group #CME4OD Join here! https://t.co/d6KZUQAAvX #ThinkDeeper #ODPhilosophy #PracticeTheSameProfession #Optometry https://t.co/fLyzcVsvvK
RT @ParsingScience: Patients who experience untreated "white coat hypertension" - high blood pressure while at doctors office, but lower ou…
Patients who experience untreated "white coat hypertension" - high blood pressure while at doctors office, but lower outside it - found to have double the risk of death from heart disease. https://t.co/rPKdFpnRRp
RT @UpdateonScience: https://t.co/SqZBAz9xQA Patients with untreated white coat hypertension—high blood pressure in the doctor’s office, bu…
https://t.co/SqZBAz9xQA Patients with untreated white coat hypertension—high blood pressure in the doctor’s office, but low blood pressure outside the office—are at double the risk of death from heart disease, study finds. #sciencenews https://t.co/cYTqRuwO2B
@AnnalsofIM HTA de bata blanca sin tratar , se asocia con un mayor riesgo de eventos cardiovasculares y mortalidad por todas las causas. Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis https://t.co/8ckJHW8bL0
Cardiovascular Events and Mortality in White Coat Hypertension A Systematic Review and Meta-analysis,,https://t.co/MYzvqEXOX9,
RT @SupremeCmdr: Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis https://t.co/iw5dj58…
Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis https://t.co/iw5dj58a2n
RT @TodaysHospital: Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis https://t.co/zVJD…
Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis https://t.co/zVJDKRGSMj
RT @SaludBmanga:
RT @SaludBmanga:
RT @emas_online: Cardiovascular Events in White Coat #Hypertension systematic review and meta analysis concludes out-of-office BP monitorin…
Cardiovascular Events in White Coat #Hypertension systematic review and meta analysis concludes out-of-office BP monitoring is critical in the diagnosis and management of hypertension. https://t.co/D8z7WGLhNx
RT @ASPNeph: Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/OZqP7IKhuU…
RT @ASPNeph: Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/OZqP7IKhuU…
Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/OZqP7IKhuU @AnnalsofIM Tx @drjosflynn for sharing
RT @the_paper_link: [trend] new: *Cohen JB* et al (Ann Intern Med) **Cardiovascular Events and Mortality in White Coat Hypertension: A Syst…
[trend] new: *Cohen JB* et al (Ann Intern Med) **Cardiovascular Events and Mortality in White Coat Hypertension: A Systematic Review and Meta-analysis.** https://t.co/uRN4vJdMzZ
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @GlobalPHObserv: Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/tQk…
RT @GlobalPHObserv: Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/tQk…
RT @GlobalPHObserv: Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/tQk…
RT @GlobalPHObserv: Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/tQk…
Cardiovascular Events and Mortality in White Coat #Hypertension: A Systematic Review and Meta-analysis https://t.co/tQkXhzci12
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
RT @jordy_bc: Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo…
Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? https://t.co/KLPo7wHUmK #bloodpressure #heartdisease @AnnalsofIM @UPennDBEI @PennKidney @PennMedNews 1/4
Due to mixed results across the existing literature, we asked: Does white coat #hypertension really matter? http://annals.org/aim/article/doi/10.7326/M19-0223 #bloodpressure #heartdisease @AnnalsofIM @UPennDBEI @PennKidney @PennMedNews 1/4
JM
EA
OD
AN
SS
E
CP
RL
WA
SC
AB
ML
JS
M
AU
JM
KJ
KP
J
PK
AP
SS
L
楠
M
篤
カ
R
ジ
ち
蕎
NY
名
名
の
U夕
まP
AP
は
C
け
ヒ
S
青発
SS
OP
PS
SN
HB
HF
GL
TH
LD
AM
EE
D
TL
AM
KC
LE
EH
CE
GO
DK
CC
AC
DB
D
SH
JL
DI
PM
MM